| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 358 |
| 1 | PRAMIPEXOLE | 202 |
| 2 | QUETIAPINE | 189 |
| 3 | ARIPIPRAZOLE ORAL | 157 |
| 4 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 157 |
| 5 | RASAGILINE MESYLATE | 116 |
| 6 | CARBIDOPA AND LEVODOPA | 106 |
| 7 | PRAMIPEXOLE DIHYDROCHLORIDE | 105 |
| 8 | LEVODOPA | 99 |
| 9 | OLANZAPINE | 98 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L DOPA | 6 | 0.0224 |
| 1 | PRAMIPEXOLE DIHYDROCHLORIDE | 105 | 0.0217 |
| 2 | TOLCAPONE | 5 | 0.0142 |
| 3 | BROMOCRIPTINE MESYLATE | 9 | 0.0139 |
| 4 | PRAMIPEXOLE | 202 | 0.0129 |
| 5 | ZIPRASIDONE HCL | 34 | 0.0128 |
| 6 | SELEGILINE HYDROCHLORIDE | 7 | 0.0119 |
| 7 | RASAGILINE MESYLATE | 116 | 0.0103 |
| 8 | ENTACAPONE | 35 | 0.0082 |
| 9 | SELEGILINE | 22 | 0.0073 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 510 |
| 1 | Benzodiazepine [EPC] | 238 |
| 2 | Aromatic Amino Acid [EPC] | 212 |
| 3 | Nonergot Dopamine Agonist [EPC] | 153 |
| 4 | Anti-epileptic Agent [EPC] | 119 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 116 |
| 6 | Mood Stabilizer [EPC] | 115 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 85 |
| 8 | Influenza A M2 Protein Inhibitor [EPC] | 66 |
| 9 | Catechol-O-Methyltransferase Inhibitor [EPC] | 53 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catechol-O-Methyltransferase Inhibitor [EPC] | 53 | 0.0105 |
| 1 | Nonergot Dopamine Agonist [EPC] | 153 | 0.0098 |
| 2 | Monoamine Oxidase Inhibitor [EPC] | 22 | 0.0071 |
| 3 | Ergot Derivative [EPC] | 30 | 0.0061 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 66 | 0.0042 |
| 5 | Aromatic Amino Acid [EPC] | 212 | 0.0035 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 85 | 0.0030 |
| 7 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 8 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 14 | 0.0018 |
| 9 | Atypical Antipsychotic [EPC] | 510 | 0.0011 |